Journal Year Published

1
1

Author

2
201
181
149
139
133
133
125
123
108
105
95
82
78
63
62
54
50
46
43
43

Journal

1
1

NCATS Publications

Targeting AML-associated FLT3 mutations with a type I kinase inhibitor.


Jones LM, Melgar K, Bolanos L, Hueneman K, Walker MM, Jiang J, Wilson K, Zhang X, Shen J, Jiang F, Sutter P, Wang A, Xu X, Tawa G, Hoyt S, Wunderlich M, O'Brien E, Perentesis JP, Starczynowski DT, Thomas C


J. Clin. Invest. , (130), 2017-2023, 2020.

Article Pubmed

Sample image from publication page

Overcoming adaptive therapy resistance in AML by targeting immune response pathways.


Melgar K, Walker MM, Jones LM, Bolanos LC, Hueneman K, Wunderlich M, Jiang J, Wilson K, Zhang X, Sutter P, Wang A, Xu X, Choi K, Tawa G, Lorimer D, Abendroth J, O'Brien E, Hoyt S, Berman E, Famulare CA, Mulloy JC, Levine RL, Perentesis JP, Thomas C, Starczynowski DT


Sci Transl Med , (11), 2019.

Article Pubmed

Sample image from publication page